Application Information

This drug has been submitted to the FDA under the reference 021911/001.

Names and composition

"BANZEL" is the commercial name of a drug composed of RUFINAMIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021911/001 BANZEL RUFINAMIDE TABLET/ORAL 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
021911/002 BANZEL RUFINAMIDE TABLET/ORAL 200MG
021911/003 BANZEL RUFINAMIDE TABLET/ORAL 400MG
201367/001 BANZEL RUFINAMIDE SUSPENSION/ORAL 40MG per ML

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021911/001 BANZEL RUFINAMIDE TABLET/ORAL 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
021911/002 BANZEL RUFINAMIDE TABLET/ORAL 200MG
021911/003 BANZEL RUFINAMIDE TABLET/ORAL 400MG
201367/001 BANZEL RUFINAMIDE SUSPENSION/ORAL 40MG per ML
204988/001 RUFINAMIDE RUFINAMIDE TABLET/ORAL 200MG
204988/002 RUFINAMIDE RUFINAMIDE TABLET/ORAL 400MG
205075/001 RUFINAMIDE RUFINAMIDE TABLET/ORAL 200MG
205075/002 RUFINAMIDE RUFINAMIDE TABLET/ORAL 400MG
205095/001 RUFINAMIDE RUFINAMIDE TABLET/ORAL 200MG
205095/002 RUFINAMIDE RUFINAMIDE TABLET/ORAL 400MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved